Literature DB >> 10482963

Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene.

L A Larsen1, I Fosdal, P S Andersen, J K Kanters, J Vuust, G Wettrell, M Christiansen.   

Abstract

We describe a Swedish family with the proband and his brother suffering from severe Romano-Ward syndome (RWS) associated with compound heterozygosity for two mutations in the KVLQT1 (also known as KCNQ1 and KCNA9) gene (R518X and A525T). The mutations were found to segregate as heterozygotes in the maternal and the paternal lineage, respectively. None of the heterozygotes exhibited clinical long QT syndrome (LQTS). No hearing defects were found in the proband. The data strongly indicates that the compound heterozygosity for R518X and A525T is the cause of an autosomal recessive form of RWS in this family. Our findings support the implication of a higher frequency of gene carriers than previously expected. We suggest that relatives of 'sporadic RWS' patients should be considered potential carriers, at risk of dying suddenly from drug-induced LQTS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482963     DOI: 10.1038/sj.ejhg.5200323

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

Authors:  Martin H Ruwald; Xiaorong Xu Parks; Arthur J Moss; Wojciech Zareba; Jayson Baman; Scott McNitt; Jorgen K Kanters; Wataru Shimizu; Arthur A Wilde; Christian Jons; Coeli M Lopes
Journal:  Heart Rhythm       Date:  2015-08-28       Impact factor: 6.343

Review 2.  Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians.

Authors:  Melanie Care; Vijay Chauhan; Danna Spears
Journal:  Curr Cardiol Rep       Date:  2017-08-16       Impact factor: 2.931

3.  KCNQ1 and KCNE1 K+ channel components are involved in early left-right patterning in Xenopus laevis embryos.

Authors:  Junji Morokuma; Douglas Blackiston; Michael Levin
Journal:  Cell Physiol Biochem       Date:  2008-04-24

4.  Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different?

Authors:  Zahurul A Bhuiyan; Safar Al-Shahrani; Ayman S Al-Khadra; Saleh Al-Ghamdi; Khalaf Al-Khalaf; Marcel M A M Mannens; Arthur A M Wilde; Tarek S Momenah
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

5.  Prevalence and potential genetic determinants of sensorineural deafness in KCNQ1 homozygosity and compound heterozygosity.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Circ Cardiovasc Genet       Date:  2013-02-07

6.  Structure of a Ca(2+)/CaM:Kv7.4 (KCNQ4) B-helix complex provides insight into M current modulation.

Authors:  Qiang Xu; Aram Chang; Alexandra Tolia; Daniel L Minor
Journal:  J Mol Biol       Date:  2012-11-23       Impact factor: 5.469

7.  Storage policies and use of the Danish Newborn Screening Biobank.

Authors:  B Nørgaard-Pedersen; D M Hougaard
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

8.  Predicting the Functional Impact of KCNQ1 Variants of Unknown Significance.

Authors:  Bian Li; Jeffrey L Mendenhall; Brett M Kroncke; Keenan C Taylor; Hui Huang; Derek K Smith; Carlos G Vanoye; Jeffrey D Blume; Alfred L George; Charles R Sanders; Jens Meiler
Journal:  Circ Cardiovasc Genet       Date:  2017-10

9.  Fast two-stage phasing of large-scale sequence data.

Authors:  Brian L Browning; Xiaowen Tian; Ying Zhou; Sharon R Browning
Journal:  Am J Hum Genet       Date:  2021-09-02       Impact factor: 11.025

10.  Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing.

Authors:  Eva-Lena Stattin; Ida Maria Boström; Annika Winbo; Kristina Cederquist; Jenni Jonasson; Björn-Anders Jonsson; Ulla-Britt Diamant; Steen M Jensen; Annika Rydberg; Anna Norberg
Journal:  BMC Cardiovasc Disord       Date:  2012-10-25       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.